James H. Mackaness, Chief Financial Officer at SOLENO THERAPEUTICS INC (SLNO), sold 8,372 shares at $28.65 ($240K) on 2023-11-30, disclosed to the SEC on 2023-12-04.
Open-market sale of $240k SLNO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.65 | 4,186 | $120K | 50.0% |
| 2 | $28.65 | 4,186 | $120K | 50.0% |
| Total | $28.65 avg | 8,372 | $240K | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |